Login to Your Account



Financings Roundup

IPOpalooza Continues with Portola's $122M Offering

By Catherine Shaffer
Staff Writer

Thursday, May 23, 2013
Portola Pharmaceuticals Inc. has become the latest biotech to go public in a rush driven by surging financial markets. The South San Francisco-based company has become the 12th biotech in the 2013 IPO class, and another dozen are filed and pending, signaling a definitive end to the long wait for markets to regain avid interest in new biotech opportunities following the market crash of 2008.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription